Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국
일요일, 8월 30

Bausch Health Companies Inc

BHCNYSE
Trade with Public
Trade with Public
$6.32
0.020.32%
가까이에: Aug 28, 5:00 PM EST
$6.32
N/A
시간외: Aug 28, 4:00 PM EST
개요뉴스실적 전망이벤트목표가재무심리지분 현황비교옵션주식 보고서

Bausch Health Companies Analyst Price Targets

Wall Street analyst price targets and consensus rating for Bausch Health Companies (BHC).

Price Target Range — 10 Quarters

Analyst Consensus — 5 Analysts

4Hold
1Sell
Consensus RatingHold# Analysts5Avg. Consensus PT$7Upside to Avg. PT+13.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Apr 27, 2026RBC CapitalDouglas MiehmPT CutSector Perform$10→$9
Feb 25, 2026BarclaysGlen SantangeloPT CutEqual-Weight$8→$7
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
RBC Capital Maintains Sector Perform on Bausch Health Companies, Lowers Price Target to $9

RBC Capital analyst Douglas Miehm maintains Bausch Health Companies (NYSE:BHC) with a Sector Perform and lowers the price target from $10 to $9.
Benzinga Newsdesk

PRO
Barclays Maintains Equal-Weight on Bausch Health Companies, Lowers Price Target to $7

Barclays analyst Glen Santangelo maintains Bausch Health Companies (NYSE:BHC) with a Equal-Weight and lowers the price target from $8 to $7.
Benzinga Newsdesk

PRO
Truist Securities Maintains Hold on Bausch Health Companies, Raises Price Target to $8

Truist Securities analyst Les Sulewski maintains Bausch Health Companies (NYSE:BHC) with a Hold and raises the price target from $7 to $8.
Benzinga Newsdesk

PRO
Barclays Initiates Coverage On Bausch Health Companies with Equal-Weight Rating, Announces Price Target of $8

Barclays analyst Glen Santangelo initiates coverage on Bausch Health Companies (NYSE:BHC) with a Equal-Weight rating and announces Price Target of $8.
Benzinga Newsdesk

PRO
RBC Capital Maintains Sector Perform on Bausch Health Companies, Raises Price Target to $10

RBC Capital analyst Douglas Miehm maintains Bausch Health Companies (NYSE:BHC) with a Sector Perform and raises the price target from $8.5 to $10.
Benzinga Newsdesk

PRO
Jefferies Downgrades Bausch Health Companies to Hold, Lowers Price Target to $8

Jefferies analyst David Steinberg downgrades Bausch Health Companies (NYSE:BHC) from Buy to Hold and lowers the price target from $12 to $8.
Benzinga Newsdesk

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

시장 데이터 제공 Benzinga API

Benzinga

Benzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved